NCT07306715

Brief Summary

Genital apical prolapse refers to the descent of the vaginal apex, uterus, or cervix, and surgical treatment is required for adequate apical support. Laparoscopic pectopexy is a surgical method developed as an alternative to the gold standard, sacrocolpopexy, in the treatment of genital organ prolapse, especially for obese patients for whom dissection is difficult. The vaginal cuff is attached to the pectineal ligament with polypropylene mesh in the standard technique. The use of mesh is subject to serious restrictions due to complications such as mesh erosion. Surgical methods without using a mesh may be safer treatment options for patients with genital prolapse. This study aimed to compare the results of Laparoscopic Pectopexy surgery with and without the use of mesh material after hysterectomy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jan 2026Jun 2027

First Submitted

Initial submission to the registry

December 14, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 29, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 29, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

December 14, 2025

Last Update Submit

January 29, 2026

Conditions

Keywords

pectopexymesh

Outcome Measures

Primary Outcomes (1)

  • Apical descensus relapse rate

    The ratio of women with stage 2 or greater vaginal cuff prolapse according to the Pelvic Organ Prolapse Quantification (POP-Q) system.

    12 months after surgery

Secondary Outcomes (1)

  • Prolapse Quality of Life (P-QOL)

    Preoperative day and 12 months after surgery

Other Outcomes (2)

  • De novo central or lateral defect cystocele rate

    12 months after surgery

  • De novo rectocele rate

    12 months after surgery

Study Arms (2)

Laparoscopic Pectopexy without mesh

EXPERIMENTAL

In this group of patients, the Laparoscopic Pectopexy operation will be performed without the use of mesh material after hysterectomy. Not using mesh will be protective against possible erosion reactions that may develop in the postoperative period. Laparoscopic hysterectomy is performed using the standard procedure with a uterine manipulator; after sealing the uterine arteries, the vagina is cut at the level of the uterine manipulator cuff and sutured. The vaginal cuff will be fixed to the pectineal ligament with No. 1, non-absorbable Prolene suture.

Procedure: Meshless Laparoscopic Pectopexy

Laparoscopic Pectopexy with mesh

ACTIVE COMPARATOR

In this group of patients, the Laparoscopic Pectopexy operation will be performed using mesh material after hysterectomy. Laparoscopic hysterectomy is performed using the standard procedure with a uterine manipulator; after sealing the uterine arteries, the vagina is cut at the level of the uterine manipulator cuff and sutured. The vaginal cuff will be fixed to the pectineal ligament with polypropylene mesh.

Procedure: Laparoscopic Pectopexy with mesh

Interventions

The vaginal cuff will be fixed to the pectineal ligament with No. 1, non-absorbable Prolene suture.

Laparoscopic Pectopexy without mesh

The vaginal cuff will be fixed to the pectineal ligament with polypropylene mesh.

Laparoscopic Pectopexy with mesh

Eligibility Criteria

Age40 Years - 80 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale patients with symptomatic uterine prolapse
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients older than 40 years and younger than 80 years old with symptomatic uterine prolapse
  • Patients who provided written consent for the surgical procedure
  • Patients who do not wish to preserve their uterus

You may not qualify if:

  • Patients who cannot obtain anesthesia approval for laparoscopic surgery
  • Patients who have a confirmed or suspected pregnancy
  • Patients who have abnormal uterine/cervical/vaginal bleeding
  • Patients with biopsy-confirmed endometrial hyperplasia or cervical dysplasia
  • Patients with pathology-confirmed genital cancer
  • Patients undergone chemotherapy or radiotherapy for any type of cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli University, School of Medicine

Köseköy, Kocaeli, 41380, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Erdem B, Salman S, Usta ZK, Bacak HB, Ozkan MD, Ceken AT, Isik EY, Kumbasar S, Gencer FK, Baghaki HS, Kacar T, Aslan GN, Bulut B. A Novel Approach for Apical Prolapse Surgery: Meshless Pectopexy (Salman's Modification). Int Urogynecol J. 2025 Aug;36(8):1701-1705. doi: 10.1007/s00192-025-06107-z. Epub 2025 Apr 1.

    PMID: 40167602BACKGROUND
  • Aleksandrov A, Smith AV, Rabischong B, Botchorishvili R. Mesh-less laparoscopic treatment of apical prolapse. Facts Views Vis Obgyn. 2021 Jun;13(2):179-181. doi: 10.52054/FVVO.13.2.013.

    PMID: 34184848BACKGROUND

MeSH Terms

Interventions

Melanocyte-Stimulating Hormones

Intervention Hierarchy (Ancestors)

MelanocortinsPro-OpiomelanocortinHypothalamic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPituitary Hormones, AnteriorPituitary HormonesNeuropeptidesPeptidesAmino Acids, Peptides, and ProteinsNerve Tissue ProteinsProteins

Study Officials

  • İsmail Bıyık, M.D.

    Kütahya Sağlık Bilimleri University

    STUDY CHAIR

Central Study Contacts

Şener Gezer, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Şener Gezer, MD, Associate Prof., Principal Investigator, Kocaeli University, School of Medicine, Department of Obstetrics and Gynecology

Study Record Dates

First Submitted

December 14, 2025

First Posted

December 29, 2025

Study Start

January 29, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

February 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations